EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016–2022)

Parag Das, Nandana Das, Gaurav Narula, Amita Trehan, Sameer Bakhshi, Venkatraman Radhakrishnan, Rachna Seth, Prashant Tembhare, Man Updesh Singh Sachdeva, Anita Chopra, Shirley Sundersingh, Soumyadeep Das und 6 weitere

The Lancet Regional Health - Southeast Asia · 2026-07 · 50 · 100788

DOI: 10.1016/j.lansea.2026.100788 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Lancet Regional Health - Southeast Asia, 2026-07. Verfasst von Parag Das und 17 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Unit, Tata Translational Cancer Research Centre, Tata Medical Center, Kolkata, West Bengal, 700160, India. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Department of Biotechnology, Ministry of Science and Technology, India, Wellcome Trust DBT India Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Acute lymphoblastic leukaemiaChildRandomised clinical trialSteroid

Autor:innen und Institutionen

  • Clinical Research Unit, Tata Translational Cancer Research Centre, Tata Medical Center, Kolkata, West Bengal, 700160, India.
  • Department of Pediatric Oncology, Tata Memorial Centre, Tata Memorial Hospital, Mumbai, Maharashtra 400012, India.
  • Homi Bhabha National Institute, Mumbai, Maharashtra, 400 094, India.
  • Pediatric Hematology-Oncology Unit, Department of Pediatrics, Advanced Pediatrics Center, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
  • Department of Medical Oncology, BR Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, 110029, India.
  • Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu 600020, India.

Förderung

  • Wellcome Trust
  • Department of Biotechnology, Ministry of Science and Technology, India
  • Wellcome Trust DBT India Alliance
  • Tata Consultancy Services Limited
  • Indian Council of Medical Research

Zitieren

APA

Das, P., Das, N., Narula, G., Trehan, A., Bakhshi, S., Radhakrishnan, V., Seth, R., Tembhare, P., Singh Sachdeva, M. U., Chopra, A., Sundersingh, S., Das, S., Gogoi, M. P., Parihar, M., Bhattacharya, R., Banavali, S., Saha, V., & Krishnan, S. (2026). Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016–2022). The Lancet Regional Health - Southeast Asia, 50, 100788. https://doi.org/10.1016/j.lansea.2026.100788

Vancouver

Das P, Das N, Narula G, Trehan A, Bakhshi S, Radhakrishnan V, et al. Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016–2022). The Lancet Regional Health - Southeast Asia. 2026;50:100788. doi:10.1016/j.lansea.2026.100788

BibTeX
@article{Das2026,
  author = {Das, Parag and Das, Nandana and Narula, Gaurav and Trehan, Amita and Bakhshi, Sameer and Radhakrishnan, Venkatraman and Seth, Rachna and Tembhare, Prashant and Singh Sachdeva, Man Updesh and Chopra, Anita and Sundersingh, Shirley and Das, Soumyadeep and Gogoi, Manash Pratim and Parihar, Mayur and Bhattacharya, Rahul and Banavali, Shripad and Saha, Vaskar and Krishnan, Shekhar},
  title = {Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016–2022)},
  journal = {The Lancet Regional Health - Southeast Asia},
  year = {2026},
  volume = {50},
  pages = {100788},
  doi = {10.1016/j.lansea.2026.100788}
}
Kostenlos starten →